Apr 30, 2007 | Posted by: roboblogger
“With many of the original therapeutic antibody companies having been acquired and licenses to their antibody generation and protein engineering technologies no longer available, the field needs new solutions”
Amgen, Inc. Anaptys Biosciences, Inc., a product-focused biopharmaceutical company, today announced that it has named Tom Smart to the newly created position of chairman and chief executive officer. via Freshnews.com
Comments
|
Great hire!
|
|
|
Tell me when this thread is updated: |
|
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
|
|
Aug '10 | Mane | 1 |